Zelnorm (also Zelmac) is the brand name for the pharmaceutical product Tegaserod, marketed by Novartis as a remedy for irritable bowel syndrome (IBS) and constipation. Zelnorm was introduced to the U.S. market in 2002, subsequent to Food and Drug Administration (FDA) approval.
In 2007, the FDA asked Novartis to take Zelnorm off the market, based on an analysis of data by the agency. After receiving reports that Zelnorm might be tied to increased risk of stroke or heart attack, the FDA reviewed data from more than 18,000 patients. The study showed that the incidences of cardiovascular problems of people who took Zelnorm was more than 10 times the rate of those who took a placebo.
If you or someone you love has suffered injury after being prescribed Zelnorm, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
How Can a Lawyer Help You Defend Against Foreclosure?
If you fall behind on your mortgage payments, your house might end up in foreclosure. However, there…Read More 21 Oct 2019, Monday
The Google Antitrust Investigation
What’s Happening and How It May Potentially Affect Access to Legal Services Earlier this month…Read More 25 Sep 2019, Wednesday
I often am asked by clients how they can avoid probate. In some situations, it is appropriate to tak…Read More 12 Jul 2019, Friday